19
UGA COLLEGE OF PHARMACY
PUBLICATIONS
DEPARTMENT OF CLINICAL AND
ADMINISTRATIVE PHARMACY
BOOKS AND BOOK CHAPTERS
DeRemer DL. Drug and Food Interactions with Tyrosine Kinase
Inhibitors. In: Ustun C and Popat UR (eds): Chronic Myeloid Leukemia:
From Daily Management to Complicated Issues. New York, NY: Nova
Science Publishers; 2014 pp. 251-262.
Fagan SC, Hess DC. Stroke in Pharmacotherapy: A Pathophysiologic
Approach. (9th edition), DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells
BG, Posey LM, eds, McGraw-Hill, New York, NY, 2014.
Fagan SC, Alhusban A, Nichols FT: Evaluation of Neurologic Function.
in Pharmacotherapy: A Pathophysiologic Approach. (9th edition),
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds,
McGraw-Hill, New York, NY, 2014.
May J, Smith PH. Allergic Rhinitis, In: DiPiro JT, Talbert RL, Yee
GC, Matzke GR, Wells BG, Posey M. (eds) Pharmacotherapy: A
Pathophysiological Approach. 9th Edition. New York, NY, McGraw Hill,
2014 pp. 1541-1553.
Dopp JM, Phillips BG. Sleep Disorders, In: DiPiro JT, Talbert RL,
Yee GC, Matzke GR, Wells BG, Posey LM (eds): Pharmacotherapy: A
Pathophysiologic Approach, 9th Edition. McGraw-Hill, New York, NY.
2014 pp 1115-1129.
Switzer JA, Sikora A, Hess DC, Fagan SC: Minocycline for Acute
Cerebral Hemorrhage in Rational Basis for Translation in Stroke
Therapy. Frontiers in Neurotherapeutics, Micieli and Amantea, Editors;
CRC Press, Taylor and Francis Group, Boca Raton, FL, August, 2014.
Fleming VH, Phillips, BG. Atrial Fibrillation Case. In: Schwinghammer
TL, Koehler JM. Pharmacotherapy Casebook: A Patient-Focused
Approach. 9th edition. New York: McGraw-Hill, 2014.
May DW, Rao S. Gastroesophageal Reflux Disease. In: DiPiro
JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey M. (eds)
Pharmacotherapy: A Pathophysiological Approach. 9th Edition. New
York, NY, McGraw Hill, 2014:455-470.
Harper ML, May JR. Introduction to the Concept of Medication
Information In Drug Information: A Guide for Pharmacists, 6th
Edition, McGraw-Hill, New York. 2014 pp. 1 – 34.
Fravel M, Phillips BB. Constipation. In: Schwinghammer TL, Koehler
JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach.
9th ed. New York, NY: McGraw-Hill; 2014.
Spangler M, Phillips BB. Chronic Anticoagulation. In:
Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A
Patient-Focused Approach. 9th ed. New York, NY: McGraw-Hill; 2014.
PEERREVIEWED RESEARCH PAPERS
Clemmons AB, Ensley B, Hoge S, Clark S. Fixed-dose rasburicase
in overweight/obese versus normal weight patients. Journal of
Oncology Pharmacy Practice. 2014 April; 20 (Suppl 2): PP15.
Clemmons AB, Hartfranft ME, Kota V, Pantin J, Awan F, Salman H,
Jillella A. Administration of anti-thymocyte globulin: Slowing infusion
rate over a 4 day course with aggressive use of pre-medications to
reduce infusion reactions. Biology of Blood and Marrow Transplant.
2014 Feb;20(2 Suppl):S287-S288.
Clark SM, Schaack L, DeRemer D, Kota V, Clemmons AB.
Fosaprepitant for the prevention of nausea and vomiting in patients
receiving BEAM or high-dose melphalan conditioning regimens
for autologous hematopoietic stem cell transplantation. Biology of
Blood and Marrow Transplant. 2014 Feb;20(2 Suppl):S287.
Cobran EK, Wutoh AK, Lee E, Odedina F, Ragin C, Aiken W, Godley
P. (2014). Perceptions of prostate cancer fatalism and screening
behavior between United States-born and Caribbean-born black
males. Journal of Immigrant and Minority Health. 16(3):394-400.
Pen D, Stitzenberg K, Cobran EK, Godley PA. (2014).Provider-based
research network demonstrate greater hospice use for minority
patients with lung cancer. Journal of Oncology Practice. 10(4):e182-
90.
Mohamed IN, Hafez S, Ergul A, Imig JD, El-Remessy AB. HFD-
induced TXNIP expression is required for endothelial inflammasome
activation and retinal vascular degeneration. Diabetologia,
Feb;57(2):413-23, 2014.
El-Azab MF, Baldowski BR, Shanab AY, Matragoon S, Saul A, El-
Remessy AB. Neuroprotective effects of TXNIP deletion in a model of
optic neuropathy. British Journal of Pharmacology, 171(5):1299-313,
2014.
Soliman SA, Ishrat T, Pillai, A, Somanath PR, Ergul A, El-Remessy
AB, Fagan SC. Candesartan induces a prolonged proangiogenic
effect and augments endothelium-mediated neuroprotection
after oxygen and glucose deprivation: Role of vascular endothelial
growth factors A and B. Journal of Pharmacology and Experimental
Therapeutics 349(3):444-57, 2014.
Rozette N, Matragoon S, Goei S, Manasco K, El-Remessy AB.
Systemic effects of ophthalmic cyclopentolate in a model of
retinopathy of prematurity. Neonatology, 106(1):37-41, 2014.
Bland CM, Bookstaver PB, Lu ZK, Dunn BL, Rumley KF. Southeastern
Research Group Endeavor (SERGE-45). Musculoskeletal safety
outcomes of patients receiving daptomycin with HMG-CoA reductase
inhibitors. Antimicrobial Agents and Chemotheraphy. 2014
Oct;58(10):5726-31.
Ishrat T, Alhusban A, Pillai B, El-Remessy AB, Ergul A, Fagan SC. Role
of matrix metalloproteinase activity in the neurovascular protective
effects of angiotensin antagonism. Stroke Research and Treatment,
2014:560491, 2014.
Abdelsaid MA, Matragoon S, El-Remessy AB. Deletion of thioredoxin
interacting protein augments hyperoxia-induced vaso-obliteration
in a mouse model of oxygen-induced retinopathy. PLoSOne,
9(10):e110388, 2014.
Fulzele S, El-sherbini A, Ahmad S, Sangani R, Matragoon S,
El-Remessy AB, Liou. GI MicroRNA-146b-3p controls retinal
inflammation by suppressing adenosine deaminase-2 in diabetes.
BioMedical Research International, 2014.
Mysona BA, Matragoon S, Moahmed IN, Shanab AY, Farooq A,
Stephens M, Fouda A, Bartasis M, Espinosa D, El-Remessy AB.
Imbalance of proNGF/NGF as biomarker in diabetic retinopathy.
BioMed Research International. 2014.
Shanab AY, El-Azab MF, Sabbineni H, Matragoon S, El-Remessy
AB. Candesartan stimulates reparative angiogenesis in ischemic
retinopathy model: role of hemeoxygenase-1 (HO-1). Angiogenesis,
(E-Pub) Nov 2014 .